Nutraceutical Ingredient Market
The future of the global nutraceutical ingredient market looks promising with opportunities in the functional food, functional beverage, dietary supplement, animal nutrition, and cosmeceutical markets. The global nutraceutical ingredient market is expected to reach an estimated $204.4 billion by 2035 from $116.2 billion in 2027 with a CAGR of 7.3% from 2027 to 2035. The major drivers for this market are the increasing demand for natural health supplements, the rising consumer interest in functional foods, and the growing focus on preventative health ingredients.
- Lucintel forecasts that, within the type category, amino acids is expected to witness the highest growth over the forecast period due to increasing demand for protein-based dietary supplements.
- Within the application category, dietary supplements is expected to witness the highest growth over the forecast period due to growing trend of consumers pre-emptively taking care of their health and wellness.
- In terms of regions, APAC is expected to witness the highest growth over the forecast period due to in charge of our health and wellness with rising health awareness and increasing middle-class population.
Emerging Trends in Nutraceutical Ingredient Market
The nutraceutical ingredient market will pursue evidence and traceability for health outcomes during the period 2025-2027, driving market growth in different ways. Manufacturers will formulate products to meet the health and nutrition needs of different consumer segments. Clinical and regulatory validation will remain essential for product formulation and differentiation.
- Clinical Validity Functionality: The use of clinical studies to substantiate the health benefits of product ingredients will continue. Suppliers will favor clinically validated ingredients. There is strong consumer interest in clinically validated ingredients. Clinical validation will raise the status of product ingredients and favor the premium sector of the market.
- Precision Nutrition: There will be greater focus on the customization of products based on age, sex, genetics, and metabolic goals. Personalized nutrition services provided clinical and regulatory validation to make recommendations to consumers. The demand for products to improve metabolic and other health outcomes will stimulate the use of integrated and blended ingredients.
- Clean-label Sustainability: Buyers are looking for ingredients with attributes such as plant-based, traceable, and non-GMO. Impact-reducing ingredients are also of interest. Sourcing transparency is of growing interest to buyers. Several companies are utilizing fermentation to reduce their land and water usage. Sourcing and use of these ingredients will lead to a competitive edge for companies in the marketplace.
- Fermentation-based Synthesis: The use of fermentation is becoming an increasingly popular way to produce proteins, enzymes, vitamins, and other post-biotic compounds. Within the same vein, the use of fermentation to produce vitamin B12 and other proteins is becoming commonplace. The use of fermentation offers the flexibility to produce a wide variety of compounds with agricultural and yield constraints.
- Supplier and Regulatory Discipline: There is an increased demand for rigor in supply chain controls. Identity testing and purity standards are of increasing concern for suppliers. The U.S. FDA's recent concern for GMPs for supplements, in conjunction with the supply chain disruptions of 2025, strengthened geopolitical tensions and focus on supply chain controls.
Overall, the market is in a growth and expansion phase, increasing focus on regulation and controls across all facets of the value chain. Ingredient suppliers that can develop differentiated products and prove their benefits to the consumer should capture the premium in the market.
Recent Developments in the Nutraceutical Ingredient Market
Activity in the market for nutraceutical ingredients is expected to increase from 2025 to 2027 as suppliers shift focus to clinically backed botanicals and personalized nutrition and delivery. Lucintel has other trends indicating a period of waiting, as there are rising regulations, and superior trends in branded ingredients, efficiency, and effectiveness.
- Capacity Expansion: There was recent growth through expansion as ADM invested $25 million to increase capacity at its Marshall, Minnesota soy protein isolation facility (March 2025). This should reduce supply constraints for sports and nutrition and protein-rich foods and aid larger contract manufacturing (private label) throughout the next decade.
- Strategic Acquisition: There was also recent growth through a purchase as Nestle Health Science (February 2025) acquired a majority stake in Orgain, further developing Nestle's plant-based nutrition offerings.
- Technology Launch: There was recent innovation as Ingredion (April 2025) launched a fiber system for use in digestive-related and sugar-reduction claims. Fiber and other systems for improvement of taste and/or texture may facilitate the use of fiber in mass market items.
- Regulatory Approval: The European Commission granted the first approval for a product with a precision fermentation process in the EU in 2025, initiating the commercialization of this technology in the region. Innovation in the area of food ingredients is expected to stimulate investment, but costs associated with safety and traceability are expected to be barriers for a significant period of time.
- Partnership Activity: In June 2025, Kerry announced a collaboration with a microbiome company to develop postbiotic products. Kerry is one of several companies who have recently announced similar alliances to develop products derived from the microbiome. Clinical data and commercially viable manufacturing will strengthen and shorten product development timelines, and ultimately shift consumer packaged goods spending to those products.
Products and platforms based on human clinical data will dominate the market and command the largest margins. Due to the volume of commoditized products on the market, price erosion is expected. However, the market will reward suppliers who are able to develop products that meet regulatory standards and fulfill efficacy claims based on formulation. A focus on platforms rather than fragmented products will continue.
Strategic Growth Opportunities in the Nutraceutical Ingredient Market
The market for nutraceutical ingredients is expected to boom due to increasing interest in preventive healthcare, aging population and personalized nutrition between 2024 and 2026. Lucintel's report has highlighted the opportunity in clinical research and functional food space. Customized formula and on-time supply are essential for business.
- Clinically Validated Ingredients: Human clinical trials significantly enhance the value of an ingredient, justifying a price premium. NIH's database in February 2025 listed 500+ nutrition-related clinical studies. In the next 5 years, industry formulators will prioritize evidence-based contracts.
- Women's Health: Fertility and Menopause products along with other healthy-aging products created a new market. As per the census in May 2025, the older women population will double to 30 million by 2030.
- Functional Foods: The FDA, in April 2025, registered a total of 14,000 food processing facilities in U.S. Stability of food-based nutritional ingredients will help food and beverage companies formulate on-the-go meals and nutritional bars.
- Precision Nutrition: Development of customized nutrient blends is being pursued by several companies, which leads to increased demand for nutrient blends. In 2025, the European Commission accepted more than 100 health claims related to vitamins and minerals. The focus will be on the development of nutrient blends that meet specific needs of the consumer, which will result in smaller, more valuable orders.
- Sustainable Sourcing: Increasing concern about the impact of extraction on the environment will cause customers to prefer more sustainable methods of extraction. The EU regulation to prevent deforestation will be implemented by the EU from December 2025 for large companies. Legal and sustainable sources will enable companies to charge higher prices.
In the future, companies will find it necessary to prioritize quality, especially in order to maintain customer loyalty. Quality will need to be guaranteed by evidence. Especially in the case of new, innovative products, quality will play an even greater role. Consolidation of the market will continue as a result of quality failures.
Nutraceutical Ingredient Market Drivers and Challenges
The nutraceutical industry has been impacted by numerous trends like the rise of functional foods and personalized nutrition, changes in the global economy, and regulations concerning sustainability. Therefore, the nutraceutical industry has a growing number of possibilities to meet the demands of consumers. The industry still faces challenges in meeting these demands, such as supply variability, regulations and costs of doing business across international borders, and the expense of clinical studies and other validation. According to Lucintel, the nutraceutical industry must enhance its safety and affordability of its products while ensuring traceability and compliance.
The factors responsible for driving this market include:
- Aging Population: As of January 2025, the population over the age of 60 years reached over 1 billion. The increased prevalence of the aging population has changed the focus of the nutraceutical industry to develop ingredients which address the needs of this population.
- Combination of Ingredients: There has been an increase in the use of fixed dosage forms containing multiple ingredients. It is expected that during the next 3-5 years the industry will continue to develop and launch new products which contain multiple ingredients.
- Consumer Demand: There is growing demand for health-related products and services in areas including preventative health, personalized health and wellness, and optimal nutrition. There is also interest in products that promote energy, sleep, digestion, and immunity. Noncommunicable diseases, which account for about 74% of all deaths, continue to increase and further reinforce interest in health and wellness management. The interest in products that promote health and wellness management is expected to increase over the next 5 years, particularly with the increasing focus on health and wellness by the population, as well as health and wellness spending.
- Technology Advances: Improvements in biotechnology, like enzyme and microbial fermentation technology, and advances in extraction, and artificial intelligence, allow more efficient and improved extraction and processing of ingredients. In 2025, research and development focused on ingredients derived from the microbiome. New technology will allow ingredients to be used in health and wellness products to manage specific health conditions.
- Regulatory Changes: To improve public health, countries have introduced and amended laws and regulations to reduce unhealthy lifestyles, improve food safety, and require the use of scientific evidence to support health claims. From 2025 to 2027, it is expected that laws and regulations that facilitate entry into the health and wellness markets will be enacted, to protect these markets from irresponsible competitors. Suppliers of health and wellness products that meet the requirements of these new laws and regulations will have an edge in the market.
The challenges facing this market include:
- Regulatory Complexity: Rapid Advances in Technology outpace Regulatory frameworks. Safety assessments and approvals for novel botanicals and other ingredient vary from country to country. In June 2025, many companies continued to operate with multiple, independent sets of Novel Food regulations for products subject to them in North America, Europe and Asia. Divergent regulatory frameworks will increase the time and cost required to bring new products to market and increase the risk associated with products that do not have established markets, such as advanced nutrition products and personalized nutrition. Companies will be required to make greater investments in lawyers, scientists and quality assurance personnel to meet the changing regulatory frameworks.
- Supply Chain Volatility: Unpredictable changes in the political climate and unexpected weather events significantly impact the supply of starting materials. In July 2025, weather events adversely impacted agricultural production and raw materials suppliers. Raw materials suppliers will need to implement further mechanisms to maintain a reliable supply for customers including increased control over the raw materials supply chain and greater flexibility in the location of raw materials production.
- Scientific Validation and Price Pressure: Nutraceutical manufacturing encompasses several components that increase costs including clinical research, bioavailability testing, and production controls. Consumers are price sensitive and manufacturers remain cost conscious when determining the final product price. 2025 ingredient buyers were influenced by inflation and focused on performance and ingredient costs. The next 3-5 years may increase market competition for research and development of nutraceutical ingredients. Smaller firms may find it difficult to fund research and development. The best sources of supply may not meet the requirements for performance or be priced competitively.
The global trend of rising preventative healthcare and increased life sciences research may increase the market for nutraceuticals. Improvements in science, technology, and manufacturing may increase the supply of safe, affordable and fortified nutraceuticals. Regulatory flexibility may increase the commercialization of nutraceuticals and alleviate competition. It may take longer for new nutraceutical products to gain market access due to fragmented regulations. Other market competitors may take a similar approach, particularly in the next 5-7 years. Prioritizing performance, sourcing, and production may allow market competitors to meet the growing demand for health and wellness products. Understanding market trends may help competitors differentiate their products.
List of Nutraceutical Ingredient Market Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies nutraceutical ingredient market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nutraceutical ingredient market companies profiled in this report include-
- ADM
- BASF
- Cargill
- DSM
- Tate & Lyle
- Ajinomoto
- FMC
- Ingredion
- Lonza
- Evonik
Nutraceutical Ingredient Market by Segment
The study includes a forecast for the global nutraceutical ingredient market by type, application, and region.
Nutraceutical Ingredient Market by Type [Value ($B) from 2019 to 2035]:
- Amino Acids, Peptides & Proteins
- Lutein
- Zeaxanthin
- Minerals
- Polyphenols & Flavonoids
- Probiotics
- Others
Nutraceutical Ingredient Market by Application [Value ($B) from 2019 to 2035]:
- Functional Foods
- Functional Beverages
- Dietary Supplements
- Animal Nutrition
- Cosmeceuticals
Nutraceutical Ingredient Market by Region [Value ($B) from 2019 to 2035]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Country Wise Outlook for the Nutraceutical Ingredient Market
The nutraceutical ingredient market is shifting to more regulated and scaled platforms. From 2025 to 2027, companies will concentrate on the clinical certification of products. In conjunction, national authorities will progressively restrict the marketing claims and supervise the manufacture of nutraceutical ingredients. It will be essential for companies to adjust to the changing regulatory environment. According to a recent report by Lucintel, companies will have to refine their understanding of regional laws and regulations.
- United States: Between 2025 and 2027, companies will foster a culture of fibers, botanicals, and other compounds, including ingredients that have clinically been supported to be beneficial. It is expected that companies in the beverage industry will pioneer this effort. The recent acquisition of Poppi by PepsiCo for 1.95 billion dollars may accelerate the shift.
- China: Similar to other countries, China regulatory authorities have recently modified their requirements for the registration and licensing of products. In 2025, several authorities in China updated the permitted claims and ingredients that can be used in health foods. It is expected that in the coming years, several manufacturers will invest in the local market to produce health products and cater to the population's demand for safe and effective health products.
- Germany: Investment. BASF is progressing projects in Germany including its Verbund and biotech projects, and its Nutrition & Care manufacturing projects. In 2024, BASF reported group sales of €65.3 billion. Further investments are expected to strengthen BASF's process and manufacturing capacity. As EU customers are stringent about the traceability and safety of ingredients, BASF's German-based production facilities are expected to play a key role in manufacturing processes.
- India: Capacity development. Continued support for the pharma PLI scheme encouraged investments in the pharmaceutical sector and related industries, including the development of capabilities in standardized botanical and nutraceutical products by Sami-Sabinas in 2025. The Indian pharmaceutical industry recorded a significant growth and exports touched $27.9 billion in 2025. It is expected that the investments in phytochemical industry would enable self-reliance in specialty pharma ingredients.
- Japan: Product commercialization. In 2025, Kirin launched several products derived from its Lactococcus lactis plasma and other related technologies in the field of functional food and immune health. In 2024, Kirin reported a consolidated revenue of ¥2.3 trillion. It is expected that continued investments would facilitate the commercialization of high value ingredients by Japanese companies.
Features of the Global Nutraceutical Ingredient Market
- Market Size Estimates: nutraceutical ingredient market size estimation in terms of value ($M).
- Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
- Segmentation Analysis: nutraceutical ingredient market size by type, application, and region in terms of value ($M).
- Regional Analysis: nutraceutical ingredient market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the nutraceutical ingredient market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nutraceutical ingredient market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
This report answers following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the nutraceutical ingredient market by type (amino acids, peptides & proteins, lutein, zeaxanthin, minerals, polyphenols & flavonoids, probiotics, and others), application (functional foods, functional beverages, dietary supplements, animal nutrition, and cosmeceuticals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Market Overview
- 2.1 Background and Classifications
- 2.2 Supply Chain
3. Market Trends & Forecast Analysis
- 3.1 Macroeconomic Trends and Forecasts
- 3.2 Industry Drivers and Challenges
- 3.3 PESTLE Analysis
- 3.4 Patent Analysis
- 3.5 Regulatory Environment
4. Global Nutraceutical Ingredient Market by Type
- 4.1 Overview
- 4.2 Attractiveness Analysis by Type
- 4.3 Amino Acids, Peptides & Proteins : Trends and Forecast (2019 to 2035)
- 4.4 Lutein : Trends and Forecast (2019 to 2035)
- 4.5 Zeaxanthin : Trends and Forecast (2019 to 2035)
- 4.6 Minerals : Trends and Forecast (2019 to 2035)
- 4.7 Polyphenols & Flavonoids : Trends and Forecast (2019 to 2035)
- 4.8 Probiotics : Trends and Forecast (2019 to 2035)
- 4.9 Others : Trends and Forecast (2019 to 2035)
5. Global Nutraceutical Ingredient Market by Application
- 5.1 Overview
- 5.2 Attractiveness Analysis by Application
- 5.3 Functional Foods : Trends and Forecast (2019 to 2035)
- 5.4 Functional Beverages : Trends and Forecast (2019 to 2035)
- 5.5 Dietary Supplements : Trends and Forecast (2019 to 2035)
- 5.6 Animal Nutrition : Trends and Forecast (2019 to 2035)
- 5.7 Cosmeceuticals : Trends and Forecast (2019 to 2035)
6. Regional Analysis
- 6.1 Overview
- 6.2 Global Nutraceutical Ingredient Market by Region
7. North American Nutraceutical Ingredient Market
- 7.1 Overview
- 7.2 North American Nutraceutical Ingredient Market by Type
- 7.3 North American Nutraceutical Ingredient Market by Application
- 7.4 The United States Nutraceutical Ingredient Market
- 7.5 Canadian Nutraceutical Ingredient Market
- 7.6 Mexican Nutraceutical Ingredient Market
8. European Nutraceutical Ingredient Market
- 8.1 Overview
- 8.2 European Nutraceutical Ingredient Market by Type
- 8.3 European Nutraceutical Ingredient Market by Application
- 8.4 German Nutraceutical Ingredient Market
- 8.5 French Nutraceutical Ingredient Market
- 8.6 Italian Nutraceutical Ingredient Market
- 8.7 Spanish Nutraceutical Ingredient Market
- 8.8 The United Kingdom Nutraceutical Ingredient Market
9. APAC Nutraceutical Ingredient Market
- 9.1 Overview
- 9.2 APAC Nutraceutical Ingredient Market by Type
- 9.3 APAC Nutraceutical Ingredient Market by Application
- 9.4 Chinese Nutraceutical Ingredient Market
- 9.5 Indian Nutraceutical Ingredient Market
- 9.6 Japanese Nutraceutical Ingredient Market
- 9.7 South Korean Nutraceutical Ingredient Market
- 9.8 Indonesian Nutraceutical Ingredient Market
10. ROW Nutraceutical Ingredient Market
- 10.1 Overview
- 10.2 ROW Nutraceutical Ingredient Market by Type
- 10.3 ROW Nutraceutical Ingredient Market by Application
- 10.4 Middle Eastern Nutraceutical Ingredient Market
- 10.5 South American Nutraceutical Ingredient Market
- 10.6 African Nutraceutical Ingredient Market
11. Competitor Analysis
- 11.1 Product Portfolio Analysis
- 11.2 Operational Integration
- 11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
- 11.4 Market Share Analysis
12. Opportunities & Strategic Analysis
- 12.1 Value Chain Analysis
- 12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunity by Type
- 12.2.2 Growth Opportunity by Application
- 12.2.3 Growth Opportunity by Region
- 12.3 Emerging Trends in the Global Nutraceutical Ingredient Market
- 12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures
13. Company Profiles of the Leading Players Across the Value Chain
- 13.1 Competitive Analysis Overview
- 13.2 ADM
- Company Overview
- Nutraceutical Ingredient Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.3 BASF
- Company Overview
- Nutraceutical Ingredient Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.4 Cargill
- Company Overview
- Nutraceutical Ingredient Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.5 DSM
- Company Overview
- Nutraceutical Ingredient Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.6 Tate & Lyle
- Company Overview
- Nutraceutical Ingredient Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.7 Ajinomoto
- Company Overview
- Nutraceutical Ingredient Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.8 FMC
- Company Overview
- Nutraceutical Ingredient Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.9 Ingredion
- Company Overview
- Nutraceutical Ingredient Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.10 Lonza
- Company Overview
- Nutraceutical Ingredient Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 13.11 Evonik
- Company Overview
- Nutraceutical Ingredient Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
14. Appendix
- 14.1 List of Figures
- 14.2 List of Tables
- 14.3 Research Methodology
- 14.4 Disclaimer
- 14.5 Copyright
- 14.6 Abbreviations and Technical Units
- 14.7 About Us
- 14.8 Contact Us